Chronic lymphocytic leukaemia trials in Singapore

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  Where

  Singapore

  Age

  18 years and over

  People

  500 worldwide

  Run by

  BeOne Medicines

  See details and how to joinNCT06973187 · EU 2025-522860-34-00